{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:53:35Z","timestamp":1781636015259,"version":"3.54.5"},"reference-count":29,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/10826084.2025.2602836","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:45:18Z","timestamp":1766227518000},"page":"1304-1310","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Naloxone Distribution on the Inpatient Psychiatric Unit: Identifying Gaps Between Current Prescribing Practices and Patient Need"],"prefix":"10.1080","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7618-0492","authenticated-orcid":false,"given":"Kathryn","family":"Stevens","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, Mount Sinai Behavioral Health Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-2390","authenticated-orcid":false,"given":"Adelya","family":"Urmanche","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, Mount Sinai Behavioral Health Center","place":["New York, USA"]},{"name":"Department of Psychology, Appalachian State University","place":["Boone, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-8491","authenticated-orcid":false,"given":"Sean T.","family":"Lynch","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, Mount Sinai Behavioral Health Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03149.xF"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.20837"},{"key":"e_1_3_4_4_1","unstructured":"Centers for Disease Control and Prevention. (2024 May 15). U.S. overdose deaths decrease in 2023 first time since 2018. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2013.07.400"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2016.05.013"},{"issue":"3","key":"e_1_3_4_7_1","first-page":"235","article-title":"Reducing fatal opioid overdose: Prevention, treatment and harm reduction strategies","volume":"88","author":"Hawk K. F.","year":"2015","unstructured":"Hawk, K. F., Vaca, F. E., & D\u2019Onofrio, G. (2015). Reducing fatal opioid overdose: Prevention, treatment and harm reduction strategies. The Yale Journal of Biology and Medicine, 88(3), 235\u2013245.","journal-title":"The Yale Journal of Biology and Medicine"},{"key":"e_1_3_4_8_1","unstructured":"IBM Corp. (2021). IBM SPSS statistics for windows (Version 28.0)."},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.15766\/mep_2374-8265.10892"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2008.136937"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108759"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108131"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.07.014"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687630802530712"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.038"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-023-00821-z"},{"key":"e_1_3_4_17_1","unstructured":"New York City Department of City Planning. (n.d.). Population. https:\/\/www.nyc.gov\/content\/planning\/pages\/planning\/population"},{"key":"e_1_3_4_18_1","unstructured":"New York City Department of Health and Mental Hygiene. (2023 September). Unintentional drug poisoning (overdose) deaths in New York City in 2022. https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/epi\/databrief137.pdf"},{"key":"e_1_3_4_19_1","unstructured":"New York City Department of Health and Mental Hygiene. (n.d.). Overdose prevention resources for providers. https:\/\/www.nyc.gov\/site\/doh\/providers\/health-topics\/overdose-prevention-resources-for-providers.page"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00891-x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fsoc.2021.619683"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","unstructured":"Spencer M. R. Garnett M. F. Minino A. M. & March 21. (2024). Drug overdose deaths in the United States 2002\u20132022. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db491.htm","DOI":"10.15620\/cdc:135849"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-7-199904060-00019"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1439800"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.07.031"},{"key":"e_1_3_4_26_1","unstructured":"U.S. Department of Health and Human Services Office of the Surgeon General. (2018 April 5). U.S. Surgeon General\u2019s advisory on naloxone and opioid overdose. https:\/\/www.hhs.gov\/surgeongeneral\/priorities\/opioids-and-addiction\/naloxone-advisory\/index.html"},{"key":"e_1_3_4_27_1","unstructured":"U.S. Food & Drug Administration. (2023 March 29). FDA approves first over-the-counter naloxone nasal spray. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1142921"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1303424"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2025.2602836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:04:37Z","timestamp":1781633077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2025.2602836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/10826084.2025.2602836"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2025.2602836","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}